Announced Tue, 14 Apr · 12:10 IST
No Physical Share Transfer Re-Lodgement Requests in Feb & Mar 2026
Compliance View source PDF
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.9%1-day move
₹24.00
prior close
₹24.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.7+0.4+0.6+7.9+12.1+11.0+15.5+14.6+12.3+19.4+7.8-0.8+1.6
Up moveDown movePending
AI summary
Balaxi Pharmaceuticals submitted its RTA report for re-lodgement of physical share transfer requests for February and March 2026, as required by a SEBI circular dated January 30, 2026. The report shows NIL requests received, processed, approved, or rejected in both months. This is a routine compliance filing with no transfer activity during the special window period.
Likely market impact
Routine compliance filing with no transfer activity; no material impact on shareholders or stock price.